ALLMedicine™ Cardiogenic Pulmonary Edema Center
Research & Reviews 193 results
https://doi.org/10.1097/CCM.0000000000005620
Critical Care Medicine; Heldeweg MLA, Smit MR et. al.
Jul 23rd, 2022 - To determine the diagnostic accuracy of lung ultrasound signs for both the diagnosis of interstitial syndrome and for the discrimination of noncardiogenic interstitial syndrome (NCIS) from cardiogenic pulmonary edema (CPE) in a mixed ICU populatio...
https://doi.org/10.4187/respcare.09625
Respiratory Care; Moretto F, Fracazzini M et. al.
Jul 20th, 2022 - Noninvasive respiratory support (NRS) has been used to treat acute respiratory failure outside the ICU, but existing data have left many knowledge gaps for managing NRS in general wards. The primary objective of this study was to describe indicati...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250742
Critical Care (London, England); Duan J, Chen L et. al.
Jul 6th, 2022 - Heart rate, acidosis, consciousness, oxygenation, and respiratory rate (HACOR) have been used to predict noninvasive ventilation (NIV) failure. However, the HACOR score fails to consider baseline data. Here, we aimed to update the HACOR score to t...
https://doi.org/10.1002/ejhf.2602
European Journal of Heart Failure; Domínguez-Rodríguez A, Suero-Mendez C et. al.
Jul 4th, 2022 - Benzodiazepines have been used as safe anxiolytic drugs for decades and some authors have suggested they could be an alternative for morphine for treating acute cardiogenic pulmonary edema (ACPE). We compared the efficacy and safety of midazolam a...
https://doi.org/10.1016/j.ajem.2022.06.013
The American Journal of Emergency Medicine; Yang TH, Chen KF et. al.
Jun 19th, 2022 - Peri-intubation cardiac arrest is an uncommon, serious complication following endotracheal intubation in the emergency department. Although several risk factors have been previously identified, this study aimed to comprehensively identify risk fac...
Drugs 1 results see all →
Clinicaltrials.gov 47 results
https://clinicaltrials.gov/ct2/show/NCT05403619
Jun 3rd, 2022 - It was a retrospective observational study performed in a internal medicine ward of a French University Hospital. Patients were identified in the hospital database, pertinent features and eFoCUS findings were extracted and anonymized. Inclusion cr...
https://clinicaltrials.gov/ct2/show/NCT04815330
Feb 18th, 2022 - Half of the patients undergoing mechanical ventilation in intensive care have moderate to severe dyspnea. This dyspnea has a negative impact on the prognosis and quality of life in the medium term. As ECMOs, techniques for extracorporeal assistanc...
https://clinicaltrials.gov/ct2/show/NCT00458926
Nov 16th, 2021 - Project Focus The focus of this project is to improve the ventilatory management of patients with acute respiratory failure in the critical care setting by enhancing the use of non-invasive ventilation, a goal that should lead to improved outcomes...
https://clinicaltrials.gov/ct2/show/NCT04998383
Aug 10th, 2021 - Dyspnea and acute respiratory failure are among the top 5 reasons for patients to present to the emergency department (ED)(1).Supplemental oxygen therapy forms the cornerstone of resuscitation of the acutely unwell patient.Under normal circumstanc...
https://clinicaltrials.gov/ct2/show/NCT03041428
Apr 1st, 2021 - Mechanical ventilation is the cornerstone of the critically-ill patients support, providing better gas exchange conditions while respiratory muscles rest. Providing this life-support technique may be harmful on the lung tissue, last decades resear...
News 16 results
https://www.medpagetoday.com/criticalcare/sepsis/77787
Feb 1st, 2019 - The early use of norepinephrine in patients with septic shock was associated with increased shock control within 6 hours of diagnosis in a randomized, placebo-controlled trial conducted in Thailand. Patients treated with early norepinephrine in th...
https://www.medpagetoday.com/criticalcare/sepsis/77787?comment=true
Feb 1st, 2019 - The early use of norepinephrine in patients with septic shock was associated with increased shock control within 6 hours of diagnosis in a randomized, placebo-controlled trial conducted in Thailand. Patients treated with early norepinephrine in th...
https://www.mdedge.com/hematology-oncology/article/189945/aml/fda-warns-serious-side-effect-aml-treatment
Jennifer Smith
Nov 30th, 2018 - The Food and Drug Administration has issued a safety communication warning that cases of differentiation syndrome are going unnoticed in patients treated with the IDH2 inhibitor enasidenib (Idhifa). Enasidenib is FDA approved to treat adults with.
https://www.mdedge.com/hematology-oncology/article/190776/leukemia-myelodysplasia-transplantation/serious-side-effect-aml-treatment
HT Staff
Nov 30th, 2018 - Photo from Business Wire Enasidenib (Idhifa®) The U. S.
https://www.mdedge.com/emergencymedicine/article/156882/imaging/emergency-ultrasound-focused-ultrasound-respiratory
Tricia Smith, MD, Todd Taylor, MD et. al.
Jan 24th, 2018 - Acute dyspnea, with or without hypoxia, is a common patient presentation in the ED, and can be the result of a myriad of mainly cardiac, pulmonary, and metabolic conditions—many of which are life-threatening. Therefore, it is crucial to determine.